跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Sitaglimin - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Sitaglimin
Approved
STANDARD
Sitaglimin
Eskayef Pharmaceuticals Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
9d2cdd59729f5b8f
Company
Eskayef Pharmaceuticals Limited
Type
Standard
Approval Details
Approval Id
9d2cdd59729f5b8f
Drug Approval Philippines Name
Sitaglimin
Product Name
Sitaglimin
Registration Number
DRP-12881-04
Brand Name
Sitaglimin
Generic Name
Sitagliptin (as phosphate) + Metformin Hydrochloride
Dosage Form
Film-Coated Tablet
Dosage Strength
50 mg/500 mg
Manufacturer
Eskayef Pharmaceuticals Limited
Importer
Medinova Pharmaceutical Inc.
Distributor
Skymed Pharma Distributor
Company Detail Path
/organization/eskayef-pharmaceuticals-limited
Issuance Date
23 December 2024
Expiry Date
24 October 2027
Pharmacologic Category
Antidiabetic Agent (Dipeptidyl peptidase 4 (DPP-4) inhibitor/Biguanide)
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
9d2cdd59729f5b8f
Type
Standard
Back to Philippines FDA Approvals